AMP-activated protein kinase (AMPK); acetyl-coenzyme A carboxylase (ACAC) BriefCommunication Pages: 826 - 826
Adenylate cyclase activating polypeptide pituitary (ADCYAP1; PACAP); ADCYAP1 receptor type 1 (ADCYAP1R1; PAC1) BriefCommunication Pages: 840 - 840
Vesicular monoamine transporter 2 (SLC18A2; VMAT2); dopa decarboxylase (DDC; AADC); calcium channel voltage-dependent T type- α 1G subunit (CACNA1G; Cav3.1) BriefCommunication Pages: 841 - 841
In vivo, NMR-based screening of protein-protein interaction modulators BriefCommunication Pages: 847 - 847
Controlled drug release from a DNA device sensitive to orally delivered quinine BriefCommunication Pages: 848 - 848
Magnetic nanoparticles for simultaneous molecular imaging and small interfering RNA delivery BriefCommunication Pages: 849 - 849
Soluble T cell receptor (TCR) oligomers to inhibit cytotoxic T cell responses to adeno-associated virus (AAV) vector–based gene therapy BriefCommunication Pages: 851 - 851
Adeno-associated virus (AAV) vector–mediated gene transfer to induce long-lived antibodies against simian immunodeficiency virus (SIV) BriefCommunication Pages: 853 - 853
In utero adult bone marrow transplantation to treat osteogenesis imperfecta BriefCommunication Pages: 854 - 854
Transplant of porcine embryonic pancreatic tissue to treat type 1 diabetes BriefCommunication Pages: 855 - 855
129Xe biosensor for imaging peptide interactions with major histocompatibility complex class II (MHCII) protein BriefCommunication Pages: 856 - 856